Table 1.
Vehicle
|
Carbamazepine
|
|||||||
---|---|---|---|---|---|---|---|---|
Saline
|
Quinpirole
|
Saline
|
Quinpirole
|
|||||
Before | After | Before | After | Before | After | Before | After | |
Body temperature (°C) | 36.5 ± 0.2 | 36.1 ± 0.2 | 36.4 ± 0.3 | 36.6 ± 0.3 | 36.5 ± 0.2 | 36.8 ± 0.4 | 36.5 ± 0.5 | 36.7 ± 0.2 |
Heart rate (beats/min) | 384 ± 40 | 410 ± 34 | 441 ± 21 | 442 ± 31 | 417 ± 30 | 423 ± 23 | 421 ± 18 | 427 ± 18 |
Arterial blood pressure (mm Hg) | ||||||||
Systolic | 149 ± 7 | 152 ± 6 | 160 ± 7 | 154 ± 13 | 142 ± 13 | 144 ± 11 | 142 ± 6 | 149 ± 12 |
Diastolic | 94 ± 12 | 92 ± 8 | 103 ± 9 | 95 ± 12 | 99 ± 5 | 97 ± 7 | 105 ± 5 | 102 ± 7 |
pH | 7.461 ± 0.024 | 7.435 ± 0.012 | 7.465 ± 0.021 | 7.451 ± 0.024 | 7.447 ± 0.021 | 7.368 ± 0.182 | 7.462 ± 0.012 | 7.441 ± 0.012 |
pO2 (mm Hg) | 94.7 ± 12.5 | 97.2 ± 4.7 | 97.1 ± 10.0 | 108 ± 18.0 | 94.4 ± 6.8 | 98.5 ± 3.9 | 99.6 ± 5.0 | 103.2 ± 3.8 |
pCO2 (mm Hg) | 37.4 ± 3.6 | 42.4 ± 2.2 | 37.2 ± 3.1 | 35.5 ± 6.3 | 39.1 ± 2.6 | 42.4 ± 3.2 | 37.2 ± 2.0 | 39.9 ± 1.8 |
Orofacial activity duration (s) | ||||||||
Orofacial activity | 15 ± 4 | 14 ± 3 | ||||||
Calm period | 34 ± 5 | 36 ± 4 |
Values are means ± SD (n = 6) measured before and 11 min after saline or quinpirole (1 mg/kg, i.v.) injection. None of these physiological parameters was statistically significantly affected by chronic carbamazepine or quinpirole administration